Conference Mind Official Announcement - Welcome to the best reviewed Global Conference/Webinar Community:
Biomarkers current perspectives and future prospects. Biomarkers current perspectives and future prospects. Biomarkers play an important role in illuminating relationships among environmental exposures, human biology, and disease. Scientists can use biomarkers to better understand fundamental biological processes, advance exposure science, and turn research findings into practical medical and public health applications.
Team Conference Mind welcomes you all around the globe to be a part of “Global Conference on Biomarker” slotted on December 03-04, 2021. We invite speakers from around the world to our global conference/webinar and they have motivated thousands of people with hope, practically and virtually with stunning results.
Theme: “Biomarkers Current Persp
Track 1. Biomarker:
A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathological processes, or a response to a therapeutic intervention.
Track 2. Toxicology:
Toxicology is a field of science that helps us understand the harmful effects that chemicals, substances, or situations, can have on people, animals, and the environment. Biomarkers have been used in medicine and toxicology for many years to assist in diagnosing and staging disease
Track 3. Microbiome:
Microbiome is a term that describes the genome of all the microorganisms, symbiotic and pathogenic, living in and on all vertebrates. A microbiome is the community of micro-organisms living together in a particular habitat.
Track 4. Alternatives to Animal Testing:
Alternatives to Animal testing include sophisticated tests using human cells and tissues also kn
Tracks and Key Topics
- Track 3 : Microbiome
- Track 2 : Toxicology
- Track 1 : Biomarker
- Track 4 : Alternatives to Animal Testing
- Track 5 : Hormones and Breast Cancer
- Track 6 : DNA and Childhood Asthma Risk
- Track 7 : Genomic Biomarkers
- Track 8 : Cardiac Biomarkers:
- Track 9 : Immunological Biomarkers
- Track 10 : Pharmaceutical Sciences
Organizing Committee Member
The global biomarkers market is estimated to reach USD 53.34 Billion by 2021 from USD 27.95 Billion in 2016, at a CAGR of 13.8% from 2016 to 2021. Growth in the global biomarkers industry is mainly driven by factors such as increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries, the high prevalence of cancer, and new initiatives for research. On the other hand, high capital investments and low cost-benefit ratio, poorly suited regulatory and reimbursement systems, and technical issues related to sample collection and storage are the major factors restraining the growth of this market. Based on type, the biomarkers market is segmented into safety, efficacy, and validation biomarkers. The efficacy biomarkers segment is further classified into predictive, surrogate, pharmacodynamic, and prognostic biomarkers.